First-Line Selection & Algorithms
Case Clue: A 43-year-old patient presents to a community pharmacy for a blood pressure check. He quit smoking 1 year ago and walks his dog for 15 minutes daily. He takes Zyrtec 10 mg daily and occasional OTC Aleve. His physical exam reveals a BMI of 24 kg/m², BP of 134/89 mmHg, HR of 82 bpm, and a calculated 10-year PREVENT CVD risk of 2%. He has no history of DM, CKD, or ASCVD.
Question: What is this patient's blood pressure classification and the recommended initial management strategy?
What is Stage 1 Hypertension managed with non-pharmacologic lifestyle modifications alone for 3–6 months (since his 10-year PREVENT risk is < 7.5% and he has no compelling comorbidities)?
Case Clue: Elena, a 67-year-old female, presents to the clinic unmedicated for HTN. She describes a history of trial and discontinuation of several medications: Zestril caused a dry hacking cough after 3 weeks; Norvasc caused +2 bilateral leg swelling; Microzide caused severe muscle cramps and a K+ of 3.1 mEq/L; and Toprol XL caused fatigue, nightmares, and HR in the 40s.
Question: Which drug classes caused each of her 4 adverse reactions, and what specific documentation/action is required for her Zestril reaction versus a true allergy?
What is ACEi (cough; document as side effect and switch to ARB), DHP CCB (pedal edema), Thiazide diuretic (hypokalemia/cramps), and Beta-Blocker (bradycardia/nightmares)?
Case Clue: A 28-year-old female at 16 weeks gestation presents for prenatal care. Her blood pressure is confirmed at 142/92 mmHg on two separate readings 15 minutes apart. She has no prior history of HTN before pregnancy.
Question: What are the two first-line preferred oral antihypertensive medications for managing hypertension in pregnancy?
What are Labetalol and Nifedipine XL?
Case Clue: A patient presenting with severe sinus congestion reports taking OTC Sudafed (pseudoephedrine) 60 mg Q4H and Aleve (naproxen) 600 mg Q8H for the past 3 days. His clinic vitals reveal a BP of 214/124 mmHg and HR of 82 bpm. Physical exam shows upper respiratory congestion but no signs or symptoms of target organ damage.
Question: What is the primary underlying cause of this patient's acute BP elevation, and what OTC drug classes raise blood pressure?
Answer: What is drug-induced severe hypertension caused by sympathomimetic decongestants (pseudoephedrine) and NSAIDs (naproxen/Aleve)?
Case Clue: A 58-year-old male with a history of HTN, Stage 3a CKD, GERD, and depression presents for follow-up. He currently takes Amlodipine (Norvasc) 10 mg daily. Clinic BP is 136/86 mmHg, HR 80 bpm, home BP averages 138/87 mmHg, CrCl is 50 mL/min, UACR is 88 mg/g (moderate albuminuria), and 10-year PREVENT CVD risk is 12%.
Question: What is the most appropriate next evidence-based pharmacologic step to optimize his blood pressure and kidney health?
What is initiating an ACE Inhibitor or ARB (e.g., Cozaar/losartan 50 mg PO daily) to provide nephroprotection and reduce albuminuria?
Case Clue: A 69-year-old female stopped amlodipine due to pedal edema and was started on Chlorthalidone 25 mg PO daily 1 month ago. She presents for follow-up today with BP 144/82 mmHg, HR 65 bpm. Follow-up BMP labs drawn 2 weeks ago show: Na 138 mEq/L, K 3.4 mEq/L (decreased from 3.8 mEq/L baseline), SCr 1.1 mg/dL, and CrCl 58 mL/min.
Question: According to lab monitoring protocols, what action must be taken regarding her Chlorthalidone dose based on her potassium level?
Answer: What is holding/discontinuing Chlorthalidone because serum K+ dropped below 3.5 mEq/L, rechecking labs, and retrialing a lower dose once labs normalize (or adding potassium supplementation)?
Case Clue: A pregnant patient with chronic hypertension asks her pharmacist if she can take her husband's leftover Lisinopril or Losartan pills to keep her blood pressure down.
Question: Which antihypertensive drug classes are strictly contraindicated in pregnancy due to severe fetotoxicity, and what OTC daily medication should be considered at 12 weeks to reduce her risk of preeclampsia?
What are ACE inhibitors, ARBs, Direct Renin Inhibitors, MRAs, and Atenolol (strictly contraindicated due to fetal toxicity/harm); Low-dose Aspirin 81 mg daily should be considered to reduce preeclampsia risk?
Case Clue: A patient arrives at an urgent care clinic with a blood pressure of 212/122 mmHg, HR 84 bpm. He is fully alert, oriented x3, and denies headache, visual changes, shortness of breath, chest pain, or dyspnea. Physical exam and labs confirm no acute target organ damage.
Question: What is the formal clinical diagnosis for this presentation, and what is the recommended treatment plan and follow-up timing?
What is Severe Hypertension (or Hypertensive Urgency); managed by adjusting/intensifying oral outpatient medications (IV therapy in ICU is NOT indicated) with follow-up within 1–4 weeks?
Case Clue: A 50-year-old female with newly diagnosed hypertension completed a 1-month trial of DASH diet and exercise. Her BP today is 144/84 mmHg, HR 80 bpm. Baseline labs show Na 141 mEq/L, K 4.1 mEq/L, CrCl 110 mL/min, UACR 14 mg/g, and PREVENT 10-year risk of 4%.
Question: According to guideline algorithms, what is the best next step to address her blood pressure?
What is initiating double-agent first-line pharmacotherapy
Case Clue: A patient started on Lisinopril 10 mg daily presents for a mandatory 2-week follow-up BMP. Labs show serum creatinine increased from a baseline of 0.70 mg/dL to 0.92 mg/dL (a 31% increase), while serum potassium is 4.4 mEq/L.
Question: What is the specific monitoring rule and management decision for a 30%–50% increase in serum creatinine following ACEi/ARB initiation?
Answer: What is continuing current therapy without dose reduction and redrawing BMP labs in 1–2 weeks (since a SCr rise < 50% does not require holding the medication)?
Case Clue: A 54-year-old female with Type 2 Diabetes and HTN presents for follow-up. She complains of a persistent dry cough on Benazepril, so her physician discontinued it and increased HCTZ to 25 mg daily. Today her BP is 146/82 mmHg, HR 78 bpm. Labs show Na 139, K 4.0 mEq/L, CrCl 82 mL/min, and UACR 140 mg/g (moderate albuminuria). She has a documented muscle allergy to Atorvastatin.
Question: Why was increasing HCTZ insufficient, and what specific alternative first-line drug class should be initiated to treat her HTN and delay diabetic kidney disease progression?
What is initiating an ARB (e.g., Losartan/Cozaar or Diovan/valsartan) to slow diabetic nephropathy progression; (Thiazides can also modestly elevate blood glucose by 5–10 mg/dL)?
Case Clue: A patient comes to a community pharmacy asking for heartburn medication. She reports intermittent "blurry vision" over the last few days and "chest tightness limiting daily activities" since yesterday. She takes Zestoretic (lisinopril/HCTZ) 20/12.5 mg daily. The pharmacist measures her BP: Right arm 240/130 mmHg, Left arm 232/128 mmHg.
Question: What details support a diagnosis of Hypertensive Emergency, and what is the immediate required medical intervention?
What is BP > 180/120 mmHg WITH acute target organ damage (blurry vision / papilledema and cardiac chest tightness); requires immediate emergency transfer and ICU admission for continuous IV antihypertensive therapy?
Case Clue: A 75-year-old male with Stage 4 CKD, HTN, and dyslipidemia is evaluated by the pharmacy team. His current regimen includes Atorvastatin 40 mg, Lisinopril 40 mg, and Metoprolol succinate 100 mg daily. He has a documented severe allergy/intolerance to Amlodipine (severe pedal edema). Labs show Na 140 mEq/L, K 4.7 mEq/L, SCr 3.0 mg/dL, CrCl 20 mL/min, and BP 136/84 mmHg, HR 65 bpm.
Question: Why are Chlorthalidone and Spironolactone contraindicated or ineffective in this patient, and which alternative drug class can be safely added if further BP lowering is required?
What is Chlorthalidone is ineffective (less effective when CrCl < 30 mL/min) and Spironolactone is contraindicated (avoid when CrCl < 30 mL/min due to severe hyperkalemia risk); an Alpha-1 blocker (Doxazosin) or Loop Diuretic (Torsemide/Furosemide) should be used instead?
Case Clue: A patient taking Amlodipine 10 mg PO daily experiences dose-dependent +2 pitting pedal edema. She is reluctant to lower her amlodipine dose because her blood pressure is currently well-controlled at 126/78 mmHg.
Question: What physiological vascular mechanism causes DHP-CCB pedal edema, and what first-line antihypertensive class can be co-administered to relieve this edema without stopping CCB therapy?
What is selective arterial vasodilation without venodilation (causing capillary fluid leakage); co-administering an ACE Inhibitor or ARB causes post-capillary venodilation, relieving CCB-induced pedal edema?
Case Clue: A nursing mother with postpartum hypertension requires pharmacological treatment. She wants to ensure her medication regimen is safe for her infant and will not impact her milk supply.
Question: Which antihypertensive drug classes should be avoided because they reduce breast milk production, and which specific agents are preferred during breastfeeding?
What is avoiding Diuretics (which decrease breast milk production) as well as ACEi/ARBs; preferred agents include Labetalol, Propranolol, Methyldopa, or Hydralazine?
Case Clue: An adult patient with a Hypertensive Emergency (BP 220/130 mmHg) is admitted to the ICU for continuous IV antihypertensive infusion.
Question: What is the guideline-mandated target rule for Systolic Blood Pressure (SBP) reduction during the first hour, the next 2–6 hours, and the subsequent 24–48 hours?
What is reducing SBP by a maximum of 20% in the first hour, then to < 160/100–110 mmHg over the next 2–6 hours, and achieving < 130/80 mmHg over the next 24–48 hours?
Case Clue: A 60-year-old male with persistent hypertension is taking max-dose triple therapy: Lisinopril 40 mg daily, Amlodipine 10 mg daily, and Chlorthalidone 25 mg daily. His fill history confirms strict adherence, and he measures BP at home using a validated cuff. Today's clinic BP is 138/88 mmHg, HR 76 bpm. Labs show Na 137 mEq/L, K 3.9 mEq/L, CrCl 78 mL/min, and 10-year PREVENT risk of 37%.
Question: What is the single best evidence-based 4th-line agent to add to his regimen to manage his resistant hypertension?
Answer: What is initiating Spironolactone 25 mg PO once daily (an Aldosterone Antagonist/MRA)?
Case Clue: A patient prescribed Prinivil (lisinopril) develops acute swelling of the lip, tongue, and uvula requiring emergency evaluation.
Question: What critical administrative and clinical steps must be completed in the medical record, and what is the rule regarding future exposure to ACE inhibitors versus ARBs?
What is immediately discontinuing lisinopril, documenting the event as a true Drug Allergy (Angioedema), permanently avoiding all ACE inhibitors, and exercising extreme caution (or avoiding) ARBs if angioedema was severe?
Case Clue: A 62-year-old Black male with Stage 2 Hypertension (BP 148/92 mmHg) and no history of chronic kidney disease or diabetes presents for initial treatment.
Question: According to guideline recommendations for Black patients without CKD, which two specific first-line drug classes are preferred for initial monotherapy or combination therapy?
What are long-acting Dihydropyridine CCBs (e.g., Amlodipine) or Thiazide-type diuretics (e.g., Chlorthalidone / HCTZ)?
Case Clue: Marcus, a patient with Stage 3a CKD (eGFR 51 mL/min, UACR 110 mg/g) and Obstructive Sleep Apnea (OSA), remains uncontrolled at 148/90 mmHg despite taking Lisinopril 40 mg, Amlodipine 10 mg, and HCTZ 25 mg daily. Medication history reveals he takes OTC Ibuprofen 400 mg 2–3 times daily for back stiffness over the past 6 months. He recently started using his CPAP machine.
Question: What two non-pharmacologic/medication-reconciliation steps must be taken to address his pseudo-resistance before declaring his hypertension truly resistant?
What is discontinuing the interfering NSAID (Ibuprofen) and confirming CPAP adherence for his OSA (secondary cause evaluation)?